SEC22B modulates ClC-5/TMEM9 trafficking and serves as a urinary marker for Dent's Disease.
Journal: Journal of translational medicine
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Durán M, Casal-Pardo A, Sarró E, et al. (2026). "SEC22B modulates ClC-5/TMEM9 trafficking and serves as a urinary marker for Dent's Disease.". Journal of translational medicine. https://doi.org/10.1186/s12967-026-08760-4